Dr Reddy’s Laboratories on Wednesday said it has initiated a voluntary nationwide recall of all its ranitidine medications sold in the US due to contamination with probable cancer causing N-Nitrosodimethylamine (NDMA). The recall started on…
Tagged By Reddy’s
Dr Reddy’s to buy eight products In US For $350 Million
New Delhi: Dr Reddy’s Laboratories has inked a percent with Teva Pharmaceutical and an associate of Allergan percent to shop for a portfolio of eight abbreviated new drug packages (ANDAs) inside the US for $350…
Dr Reddy’s Laboratories to shop for eight capsules From Teva Pharmaceutical, shares gain
The mixed income of the branded versions of the goods inside the US is around $3.five billion, Dr Reddy’s said. extra From market Sensex Snaps four-Day dropping Streak, Ends 331 factors better Sensex Set To…